portfolio overview  versant ventures search for versant ventures on linkedin share lp access contact us careers partnering to improve healthcare we are proud of our track record of working with extraordinary scientists entrepreneurs and business leaders to build transformational companies that impact and improve healthcare we invest our time talent leadership and expertise in all our portfolio partnerships we pursue opportunities where we can add value through our handson collaborative approach and devote the appropriate mix of strategic advice domain expertise and capital to help accelerate their growth we invest in life and in success since our inception in  we have invested in over  seed early and growth stage companies – of which  have gone public or been acquired to date contact us  versant ventures search for versant ventures on linkedin share lp access contact us careers contact us at one of our five offices san francisco one sansome suite  san francisco ca  phone   fax   new york  west st street suite  new york ny  phone   minneapolis  equitable drive suite  eden prairie mn  phone   basel switzerland versant ventures switzerland gmbh aeschenvorstadt  ch basel switzerland phone      canada versant ventures canada limited  great northern way suite  vancouver bc vt t phone   medical devices archives  versant ventures search for versant ventures on linkedin share lp access contact us careers medical devices ebb therapeutics oakmont pa ebb is developing a therapeutic device for insomnia inari medical irvine ca inari medical is a medical device company pioneering innovative devices for the interventional treatment of vascular thrombi and emboli metavention minneapolis mn metavention is developing novel interventional therapies for type  diabetes sebacia duluth ga sebacia is developing a medical device to cure acne zyga technology minneapolis mn zyga is developing and marketing innovative minimally invasive surgical solutions to treat conditions of the spine rox medical san clemente ca rox is developing devices for treatment of diseases of the respiratory system respicardia minnetonka mn respicardia is developing an implantable system to treat central sleep apnea in patients with heart failure orametrix richardson tx orametrix is a leading industry provider of innovative d technology solutions facilitating and improving the quality of orthodontic care neurotech pharmaceuticals lincoln ri neurotech pharmaceuticals is pioneering encapsulated cell technology as a drug delivery platform for retinal degenerative diseases minerva surgical cupertino ca minerva is developing next–generation technology for treating excessive menstrual bleeding microfabrica van nuys ca microfabrica has developed a broad microscale platform for minimally invasive procedures and for complex dynamic implants intuity medical sunnyvale ca intuity medical formerly rosedale is developing a handheld all inone discrete bloodbased diagnostic platform that will enhance glucose monitoring for diabetic patients holaira plymouth mn novel devices to treat obstructive lung disease  previously innovative pulmonary solutions halscion suwanee ga halscion is advancing a solution for reduction of surgically induced scarring forsight vision  menlo park ca forsight vision is evaluating a variety of technologies to address important unmet patient needs in key ophthalmic markets forsight vision  menlo park ca forsight vision  inc is developing novel ocular drug delivery technologies ceterix orthopedics fka suturepro technologies inc menlo park ca ceterix is developing a new orthopedic suturing technology that is focused on improving easeofuse and operative speed celula san diego ca celula is developing rare cell isolation technology for diagnostic and therapeutic purposes benvenue medical santa clara ca benvenue medical is developing and marketing innovative spine repair technology alterg fremont ca alterg is marketing its “gtrainer” technology a treadmill system that reduces the users’ body weightimpact of running and thereby enhances physical rehabilitation from orthopedic or neurological injury acufocus irvine ca acufocus is developing a corneal implant to treat presbyopia the need for reading glasses portfolio companiesbiotechnology biotechnology exits  ipos medical devices medical device exits  ipos additional investments additional investment exits discovery engines case studies amira pharmaceuticals inception  inc quanticel pharmaceuticals biotechnology archives  versant ventures search for versant ventures on linkedin share lp access contact us careers biotechnology venatorx pharmaceuticals malvern pa venatorx is a developing nextgeneration antibiotics to treat multidrug resistant mdr infections vividion therapeutics san diego ca vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteomewide drug and target discovery repare therapeutics montreal canada repare is developing new precision oncology drugs for patients that target specific vulnerabilities of tumor cells northern biologics toronto canada northern biologics is developing novel therapeutic antibodies for the treatment of human diseases in oncology fibrosis and other diseases piqur therapeutics basel switzerland piqur is a swiss pharmaceutical company focusing on the discovery and development of innovative small molecule therapeutics based on lipid kinase pik and mtor inhibition for the treatment of cancer as well as other indications anokion ecublens switzerland anokion is focused on leveraging its proprietary immune tolerance technology to develop novel protein therapeutics and treatments for autoimmune diseases mosaic biomedicals barcelona spain mosaic biomedicals is a barcelonabased company that develops personalized cancer treatments with a dual mechanism of action to eliminate cancer stem cells and reactivate the tumor’s immune system mosaic’s innovative treatments are derived from a deep understanding of the tumor biology and aim to offer safer and more effective options to cancer patients aavlife paris france aavlife is a gene therapy company focused on developing treatments for rare diseases with great unmet medical need inception ibd san diego ca inception ibd is focused on translating academic discoveries in the field of ibd into firstinclass small molecule drugs crispr therapeutics basel switzerland crispr therapeutics is making use of significant advances in the field of gene editing and focused on translating the crisprcas technology in truly transformational therapeutics for common and rare genetic diseases audentes therapeutics san francisco ca audentes is a biotechnology company committed to the development and commercialization of innovative new treatments for people with serious rare diseases through the application of gene therapy technology gensight biologics tassin la demi lune  france gensight is a leading company in gene therapy specialized in prevention of loss of vision and restoration of sight inception  san diego ca inception  is focused on the discovery of therapeutics for sensorineural hearing loss  the company has entered into a partnership with roche with a prenegotiated acquisition at ind viral logic systems technology seattle wa vlst corp has developed a novel and streamlined approach to speed the development of effective therapeutics for the treatment of inflammatory and autoimmune diseases theraclone sciences seattle wa theraclone sciences inc is focused on developing novel human therapeutic antibodies for the treatment of infectious diseases acumen san francisco ca acumen is revolutionizing the diagnosis and treatment of autism and other disorders through smartphoneenabled digital behavior evaluation improving outcomes for patients and simplifying care for specialists phaserx seattle wa phaserx is developing a novel approach to intracellular delivery of macromolecules inception  san diego ca inception  is focused on oncology the company is translating biological insights into novel firstinclass small molecule drugs for cll and other oncology indications spanning both liquid and solid tumors inception  san diego ca inception  is translating biological insights into novel firstinclass small molecule drugs to treat diseases of aging ruiyi shanghai china ruiyi is a drug discovery and development company focused on firstinclass antibodies targeting g protein coupled receptors gpcrs am ventures menlo park ca am ventures is a seedstage fund focused on creating and building biotech companies portfolio companiesbiotechnology biotechnology exits  ipos medical devices medical device exits  ipos additional investments additional investment exits discovery engines case studies amira pharmaceuticals inception  inc quanticel pharmaceuticals versant overview  versant ventures search for versant ventures on linkedin share lp access contact us careers propelling life sciences companies versant ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies the firm invests across the healthcare sector and at all stages of company development with an emphasis on the discovery and development of novel therapeutics with  billion under management and offices in north america and europe versant has built a team with deep investment operating and scientific expertise that enables a handson approach to company building since the firm’s founding in  nearly  versant companies have achieved successful acquisitions or ipos versant in europe versant ventures has a team in basel switzerland dedicated to working with entrepreneurs industry and leading academics across europe the team has decades of experience in the pharmaceutical and biotechnology industries including global roles in drug discovery research and product development for companies such as roche novartis and lilly versant’s basel office is led by tom woiwode guido magni and gianni gromo   versant overview  versant ventures search for versant ventures on linkedin share lp access contact us careers propelling life sciences companies versant ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies the firm invests across the healthcare sector and at all stages of company development with an emphasis on the discovery and development of novel therapeutics with  billion under management and offices in north america and europe versant has built a team with deep investment operating and scientific expertise that enables a handson approach to company building since the firm’s founding in  nearly  versant companies have achieved successful acquisitions or ipos versant in europe versant ventures has a team in basel switzerland dedicated to working with entrepreneurs industry and leading academics across europe the team has decades of experience in the pharmaceutical and biotechnology industries including global roles in drug discovery research and product development for companies such as roche novartis and lilly versant’s basel office is led by tom woiwode guido magni and gianni gromo   home  versant ventures search for versant ventures on linkedin share lp access contact us careers ive built two companies with versant ventures and value their distinctive investment approach they have a clear understanding of the recipe for startup company success and represent a premium brand in healthcare venture capital today david clapper  minerva surgical versant invested in life the people at versant understand the entrepreneurial process they take a longterm view of the portfolio company and help provide perspective and support in times thick and thin amar sawhney  ocular therapeutix versant invested in life versant has been and continues to be a superb investor they provide insight and counsel to our efforts and their willingness to roll up their sleeves to problem solve with us has been invaluable michael d clayman md  flexion therapeutics versant invested in life featured case study biotechnology quanticel pharmaceuticals quanticel technology is based on the work of stanford researchers and company founders stephen quake and michael clarke versant had backed other genomic technologies invented by quake and moved quickly to incubate quanticel in  shortly after the company was founded the idea behind quanticel’s singlecell genomic analysis technology is to unlock the mystery of cancer drug resistance through the analysis of tumor cell heterogeneity as a tumor grows and cancer cells rapidly replicate the genetic diversity of these cells increases full quanticel pharmaceuticals case study news highlights venatorx pharmaceuticals raises  million series b venatorxfinal repare therapeutics raises us million series a repare therapeutics raises us million series a crispr therapeutics announces the appointment of jon terrett phd to head of immunooncology research and translation crispr appoints jon terrett versant ventures launches jecure therapeutics jecureseriesa versant ventures  office in sharon height foursquarelog insign upnearbyget inspiredtop pickstrendingfoodcoffeenightlifefunshoppingversant venturesofficesharon height menlo parksavesharetipsphotos versant venturesno tips and reviewslog in to leave a tip herepostno tips yetwrite a short note about what you liked what to order or other helpful advice for visitors photorelated searchesversant ventures menlo park  versant ventures menlo park photos  versant ventures menlo park location  versant ventures menlo park address  versant ventures menlo park  versant ventures menlo park  versant ventures sharon height menlo parkaboutblogbusinessescitiesdevelopershelpjobscookies updatedprivacy updatedtermsenglishenglish français deutsch bahasa indonesia italiano  한국어 português русский español ภาษาไทย türkçe citiesatlantaaustinbostonchicagodallasdenverhoustonlas vegaslos angelesnew yorkphiladelphiaportlandsan diegosan franciscoseattlewashington dccountriesbelgiumbrazilcanadachilefinlandfrancegermanygreat britainhungaryindonesiajapanmexiconetherlandsphilippinesrussiasingaporespainthailandturkeymore great places in menlo parkabcdefghijklmnopqrstuvwxyzfoursquare    lovingly made in nyc  sfversant ventures sand hill rdmenlo park ca united statesget directions see moreunited states » san mateo county » menlo park » sharon heightis this your business claim it nowmake sure your information is up to date plus use our free tools to find new customersyou must enable javascript to use foursquarecomwe use the latest and greatest technology available to provide the best possible web experienceplease enable javascript in your browser settings to continuedownload foursquare for your smart phone and start exploring the world around you versant venture management llc private company information  bloomberg july    am et capital markets company overview of versant venture management llc snapshot people company overview versant venture management llc is a venture capital and private equity firm specializing in incubation seed startups growth stage early stage and later stage investments it seeks to invest in all segments of healthcare including discovery and development of novel therapeutics medical devices and diagnostics medtech life sciences that include biopharmaceuticals and biotechnology platforms healthcare services healthcare information technology industry specific software and healthcare industry software the firm prefers to invest in companies based in the united states and western europe the firm seeks to invest in the biotechnology sector in canada the firm typically invests b versant venture management llc is a venture capital and private equity firm specializing in incubation seed startups growth stage early stage and later stage investments it seeks to invest in all segments of healthcare including discovery and development of novel therapeutics medical devices and diagnostics medtech life sciences that include biopharmaceuticals and biotechnology platforms healthcare services healthcare information technology industry specific software and healthcare industry software the firm prefers to invest in companies based in the united states and western europe the firm seeks to invest in the biotechnology sector in canada the firm typically invests between  million and  million into each startup before it’s sold or goes public it will not invest in a company unless it has at least  million in annualized potential in the united states the firm also backs companies developing products that must go through the food and drug administration’s premarket approval process pma versant ventures was founded in  and is headquartered in san francisco california with additional offices in san diego california new york new york eden prairie minneapolis basel switzerland and vancouver canada detailed description one sansome streetsuite san francisco ca united statesfounded in  phone  fax  wwwversantventurescom key executives for versant venture management llc ms barbara n lubash ms managing director mr donald b milder managing director age  mr brian g atwood veracyte cofounder  md age  mr william j link phd cofounder  md age  mr samuel d colella mba managing director age  compensation as of fiscal year  versant venture management llc key developments versant ventures inc presents at the medtech conference jun may   versant ventures inc presents at the medtech conference jun venue the loews minneapolis hotel  st ave n minneapolis mn  united states presentation date  speakers jun kevin hykes operating partner bayer and versant ventures join forces to launch stem cell therapy company bluerock therapeutics dec   bayer ag and versant ventures announced the launch of bluerock therapeutics a nextgeneration regenerative medicine company that plans to develop induced pluripotent stem cell ipsc therapies to cure a range of diseases using an platform bluerock therapeutics will be led by a team and has assembled its platform through a series of strategic partnerships with academia and industry to enable bluerock therapeutics platform and pipeline bayer and versant are committing usd  million representing one of the ever series a financings for a biotech company the funds are projected to give bluerock therapeutics at least four years of runway and will allow the new company to advance a number of programs into the clinic with an initial focus on cardiovascular diseases and neurodegenerative disorders bluerock therapeutics platform is enabled by strategic partnerships with a number of leading academic and industry collaborators in the us canada and japan versant ventures inc presents at nynj ceo conference nov  am oct   versant ventures inc presents at nynj ceo conference nov  am venue apella at alexandria center  e  street new york ny  united states speakers carlo rizzuto partner similar private companies by industry company name region visory llc united states  road partners llc united states t partners llc united states jumpcom inc united states  ontario inc united states recent private companies transactions typedate target private placement july   sebacia inc private placement july   venatorx pharmaceuticals inc private placement june   repare therapeutics inc request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact versant venture management llc please visit wwwversantventurescom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one   versant ventures management llc company profile  bloomberg feedback versant ventures management llc private company company profile sector financials industry asset management subindustry private equity versant venture management llc operates a venture capital firm the company invests in medical devices biotechnology life science pharmaceuticals and healthcare sectors as well as offers investment management services versant venture management serves clients worldwide corporate information address  sansome suite  san francisco ca  united states phone  fax  web url wwwversantventurescom board members board members company robert grant myoscience inc from the web key executives brian g atwood managing directorcofounder samuel d colella sam managing directorcofounder ross a jaffe managing directorcofounder william j link bill managing directorcofounder barbara n lubash managing directorcofounder donald b milder don managing directorcofounder rebecca b robertson beckie managing directorcofounder robin praeger managing directorcfo kirk nielsen managing director bradley j bolzon brad managing director charles m warden managing director thomas woiwode tom managing director jerel davis managing director clare ozawa managing director gianni gromo partner guido magni partner carlo rizzuto partner alex mayweg venture partner mary haakfrendscho venture partner kevin hykes operating partner show more show less sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data   microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft second sight medical products nasdaqeyes given news impact rating of   watch list news home about staff privacy policy contact headlines business us news health world investing technology second sight medical products inc  get news  ratings daily enter your email address below to get the latest news and analysts ratings for second sight medical products inc with our free daily email newsletter follow watchlist news   latest news advanced micro devices inc nasdaqamd announces earnings results uniqure nv qure given a  price target by chardan capital analysts endo international plc nasdaqendp receives hold rating from oppenheimer holdings inc northland securities analysts give viper energy partners lp nasdaqvnom a  price target wixcom ltd nasdaqwix now covered by keycorp centerra gold inc tsecg stock rating reaffirmed by national bank financial tahoe resources inc tho stock rating reaffirmed by national bank financial new gold inc tsengd stock rating reaffirmed by national bank financial ppg industries inc ppg given a  price target by credit suisse group analysts sherwinwilliams company the nyseshw upgraded to “buy” by credit suisse group new gold inc ngd rating reiterated by national bank financial suntrust banks inc sti earns hold rating from oppenheimer holdings inc stifel nicolaus reiterates hold rating for jb hunt transport services inc jbht microsoft corporation’s nasdaqmsft neutral rating reaffirmed at mkm partners goldcorp inc g rating reiterated by national bank financial alamos gold inc agi earns outperform market weight rating from national bank financial american airlines group inc nasdaqaal given “inline” rating at imperial capital plug power inc plug stock rating reaffirmed by roth capital susquehanna bancshares inc reaffirms positive rating for super micro computer inc smci ironwood pharmaceuticals inc irwd earns outperform rating from cowen and company archives july  june  may  april  march  february  january  december  november  october  september  august  july  june  may  march  november  october  september  august  july  june  may  april  march  february  january  december  november  october  september  august  july  june  may  april  march  february  january  second sight medical products nasdaqeyes given news impact rating of  july th    comments  filed under  by lindsey winhoffer filed under investing  news sentiment articles tweet news stories about second sight medical products nasdaqeyes have been trending positive on monday according to accern sentiment analysis the research firm ranks the sentiment of news coverage by analyzing more than  million blog and news sources in realtime accern ranks coverage of publiclytraded companies on a scale of negative one to positive one with scores nearest to one being the most favorable second sight medical products earned a news sentiment score of  on accern’s scale accern also assigned news articles about the medical device company an impact score of  out of  indicating that recent news coverage is extremely unlikely to have an effect on the company’s share price in the near future here are some of the news articles that may have impacted accern sentiment analysis’s analysis second sight medical products inc  other events form k traderscom second sight medical products eyes seekingalphacom are there any catalysts to propel second sight medical products … – flbc news flbcnewscom is there strength behind the numbers for second sight medical products inc eyes – flbc news flbcnewscom long term second sight medical products inc eyes weak trend – stocks gallery stocksgallerycom shares of second sight medical products nasdaq eyes opened at  on monday second sight medical products has a  month low of  and a  month high of  the firm’s day moving average is  and its  day moving average is  the company’s market capitalization is  million second sight medical products nasdaqeyes last issued its quarterly earnings data on wednesday may rd the medical device company reported  earnings per share eps for the quarter missing analysts’ consensus estimates of  by  the business had revenue of  million for the quarter compared to analyst estimates of  million second sight medical products had a negative net margin of  and a negative return on equity of  equities research analysts predict that second sight medical products will post  eps for the current year several equities research analysts have commented on the stock hc wainwright reissued a “buy” rating and set a  price target on shares of second sight medical products in a research report on thursday july th zacks investment research cut shares of second sight medical products from a “buy” rating to a “hold” rating in a research report on thursday may th illegal activity warning “second sight medical products nasdaqeyes given news impact rating of ” was originally reported by watch list news and is the property of of watch list news if you are accessing this news story on another website it was illegally copied and republished in violation of us  international copyright  trademark law the legal version of this news story can be read at httpswwwwatchlistnewscomsecondsightmedicalproductsnasdaqeyesgivennewsimpactratingofhtml about second sight medical products second sight medical products inc is engaged in developing manufacturing and marketing prosthetic devices that restore vision to blind individuals the company’s product the argus ii system treats outer retinal degenerations such as retinitis pigmentosa rp the argus ii system provides an artificial form of vision that differs from the vision of people with normal sight receive news  ratings for second sight medical products inc daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for second sight medical products inc and related companies with analyst ratings networks free daily email newsletter lindsey winhoffer  comment on this post click here to cancel reply name required mail will not be published required website wordpress hashcash needs javascript to work but your browser has javascript disabled your comment will be placed in moderation latest news sirius xm making big investment in pandora tax reform not going quite as planned western digital files lawsuit to halt toshiba chip business sale sinclair broadcast group announces deal for tribune media starbucks has a hit with its unicorn frappuccino  watch list news llc  all rights reserved privacy policy  about  staff  contact versant venture management llc  san francisco  ca  company information products resources my account talk to a db advisor  business directory ca san francisco investors nec venture capital companies versant venture management llc v versant venture management llc claim this business  sansome st ste  san francisco ca  get directions   wwwversantventurescom business info founded  incorporated annual revenue  employee count  industries venture capital companies contacts robin l praeger contact business your email address subject message send message company summary since  versant venture management llc has been providing venture capital companies from san francisco verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   v view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved versant venture management llc  revenue and financial reports  db hoovers menu buy reports  lists how it works united states united kingdom   login company people industry search db hoovers company  people  industry login avention onesource is now db hoovers login here for access to db hoovers db datavision db business browser and isell login for customers of hoovers prior to march   login call   chat software by boldchat start free trial call   chat software by boldchat start free trial search the db hoovers database company company people industry home company information company search company overview  revenue  financial data company profile information for sales preparation marketing contacts competition revenue  financial available products company report finance and insurance sector industry report investment firms industry report venture capital industry report versant venture management llc revenue and financial data versant venture is conversant in the world of health care startups doing business as versant ventures the firm primarily invests in earlystate health care and biotech companies including medical device makers service providers pharmaceuticals and it firms it targets companies with potential sales of more than  million versant manages more than  billion in committed capital in some  portfolio firms holdings include include fluidigm cogent healthcare and metabolex a group of managing directors including samuel colella cofounded versant ventures in  financials information for versant venture management llc track this company’s financial condition view company report request your free trial income statement cash flowbalance sheetcredit rating income statement mil revenue  estimated gross profit  estimated operating income  estimated net income  estimated diluted eps  estimated cash flow mil cash at the beginning of the year  net operating cash  net investing cash  net financing cash  net change in cash  cash at end of the year  capital expenditure  assets mil current assets cash  net receivables  inventories  other income assets  asset summary total current assets  net fixed assets  other noncurrent assets  total assets  liabilities mil current liabilities accounts payable  short term debt  other current liabilities  liability summary total current liabilities  long term debt  other noncurrent liabilities  total liabilities  stakeholders equity mil equity preferred stock equity  common stock equity  equity summary total equity  shares outstanding credit rating high these businesses have a high projected rate of delinquency or a high failure risk need to go deeper no problem save time with complex financial data at your fingertips access financial statements sec filings earnings estimates and more call   to talk to a business information consultant request your free trial   free alerts to changes in your db® credit scores sign up get creditsignal® for free try db credit free for  days get started try db credit free for  days brad bolzon managing director versant venture management llc timesjavascript is disabled market profiles login sign up login sign up   edit person brad bolzon managing director at versant venture management llc location menlo park ca add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop brad bolzon managing director at versant venture management llc location menlo park ca add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop brad bolzon is both a menlo park and basel switzerlandbased managing director brad brings more than thirteen years of global pharmaceutical industry experience to versant’s biotech investment team he specializes in earlystage biotech investing with a particular emphasis on new company startups prior to joining versant brad served as executive vice president global head of business development licensing  alliances with f hoffmannla roche under his leadership roche established alliances with over  biotech companies worldwide and significantly strengthened its product pipeline previously brad held executive roles at eli lilly in drug discovery clinical research regulatory affairs and business development  companies in career na related markets na colleagues  related investments alias na industry venture capital tags na topics of influence web site na careers achievements investments related people edit view all brad bolzoncareer  ruiyi board member versant venture management llc managing director euroventures capital advisory board member flexion therapeutics board member biotie therapies board member competencies edit view all brad bolzoneducation  university of toronto university of toronto edit brad bolzonachievements and recognitions add milestone no milestones has been recorded for brad bolzon edit brad bolzonlinks add link no links has been recorded for brad bolzon brad bolzoninvestmentsacquisitions no investments has been recorded for brad bolzon view all brad bolzoninvestments representing others lead crispr therapeutics representing versant ventures since apr series a a b company status public brad bolzonrelated people no colleagues and peers has been recorded for brad bolzon view all brad bolzonrecommended market profiles  telemedicine  or more employees  companies social media marketing chiefmarteccom    employees  companies big data universe list of lists  or more employees  companies aggregated marketing technology  or more employees  companies shared economy landscape jeremiah owyang  or more employees  companies inside sales landscape  or more employees  companies home  versant ventures search for versant ventures on linkedin share lp access contact us careers ive built two companies with versant ventures and value their distinctive investment approach they have a clear understanding of the recipe for startup company success and represent a premium brand in healthcare venture capital today david clapper  minerva surgical versant invested in life the people at versant understand the entrepreneurial process they take a longterm view of the portfolio company and help provide perspective and support in times thick and thin amar sawhney  ocular therapeutix versant invested in life versant has been and continues to be a superb investor they provide insight and counsel to our efforts and their willingness to roll up their sleeves to problem solve with us has been invaluable michael d clayman md  flexion therapeutics versant invested in life featured case study biotechnology quanticel pharmaceuticals quanticel technology is based on the work of stanford researchers and company founders stephen quake and michael clarke versant had backed other genomic technologies invented by quake and moved quickly to incubate quanticel in  shortly after the company was founded the idea behind quanticel’s singlecell genomic analysis technology is to unlock the mystery of cancer drug resistance through the analysis of tumor cell heterogeneity as a tumor grows and cancer cells rapidly replicate the genetic diversity of these cells increases full quanticel pharmaceuticals case study news highlights venatorx pharmaceuticals raises  million series b venatorxfinal repare therapeutics raises us million series a repare therapeutics raises us million series a crispr therapeutics announces the appointment of jon terrett phd to head of immunooncology research and translation crispr appoints jon terrett versant ventures launches jecure therapeutics jecureseriesa versant venture management llc  company profile from hoover’s  db hoovers menu buy reports  lists how it works united states united kingdom   login company people industry search db hoovers company  people  industry login avention onesource is now db hoovers login here for access to db hoovers db datavision db business browser and isell login for customers of hoovers prior to march   login call   chat software by boldchat start free trial call   chat software by boldchat start free trial search the db hoovers database company company people industry home company information company search company overview  profile company profile information for sales preparation marketing contacts competition revenue  financial available products company report finance and insurance sector industry report investment firms industry report venture capital industry report versant venture management llccompany information  sansome st ste san francisco ca  united states  † httpwwwversantventurescom top  competitors new enterprise associates inc frazier management llc healthcare ventures llc unlock more access to hoover’s build customized email lists  based on your best customer profile learn more about the companies you want to sell to hoover’s has reports on  million companies and  industries  data points are updated each day get real insight written by real people – exclusive research and reviews by our inhouse editorial staff we can deliver our data to your desktop to excel direct to your crm into your custom app or via mobile request your free trial call   today to get started with a free trial   versant venture management llc company profile versant venture is conversant in the world of health care startups doing business as versant ventures the firm primarily invests in earlystate health care and biotech companies including medical device makers service providers pharmaceuticals and it firms it targets companies with potential sales of more than  million versant manages more than  billion in committed capital in some  portfolio firms holdings include include fluidigm cogent healthcare and metabolex a group of managing directors including samuel colella cofounded versant ventures in  † some telephone numbers on the hoover’s site may be on a country’s do not call or do not contact list including but not limited to the united kingdom’s ctps or tps registers it is a legal requirement that companies do not make sales or marketing calls to registered numbers these are central opt out registers whereby corporate subscribers and individuals can register their preference not to receive unsolicited sales and marketing telephone calls by using the information provided on the hoover’s sites as the direct marketer you represent and warrant that you will use such information in compliance with all applicable local state national or international laws and regulations including any local do not call registers or marketing regulations and agree to defend indemnify and hold harmless dun  bradstreet and each of its affiliates in the event your use violates such laws and regulations additional versant venture management llc information sales preparation get relevant industry context to prepare for your next sales call – trends competitors news call prep questions and more marketing campaigns find prospect companies that meet the profile of your best customers to maximize campaign roi strategy  planning identify new market opportunities and new strategies for existing markets credit management  finance determine and track a company’s financial condition related tags san francisco ca united states finance  insurance sector investment firms venture capital free alerts to changes in your db® credit scores sign up get creditsignal® for free try db credit free for  days get started try db credit free for  days